title: Specific dose-dependent effects of ethane 1,2-dimethanesulfonate in rat and mouse Leydig cells and non-steroidogenic cells on programmed cell death.
abstract: The mechanism by which ethane 1,2-dimethanesulfonate (EDS) selectively kills Leydig cells is poorly understood. To characterize further the cell-specific actions of EDS, we studied biochemical and morphological changes during apoptosis in different Leydig cell and non-steroidogenic cell models. Rat testicular and H540 tumor Leydig cells were killed by 1-2 mM EDS, whereas 20 mM EDS were required for MA-10 cells. This higher concentration of EDS was also necessary for activation of apoptosis in non-steroidogenic Chinese hamster ovary cells, whereas COS-1 monkey kidney cells were resistant. These variable effects of EDS on apoptosis were independent of new protein synthesis and, interestingly, could be delayed by co-incubation with dibutyrl cyclic AMP. Along with cell death, we also observed chromosomal fragmentation and other hallmarks indicative of apoptosis as evidenced by DNA laddering and fluorescent microscopy. Time-lapse photography with a confocal microscope showed that the time of onset, duration and even the sequence of apoptotic events between individual H540 cells was heterogeneous. When the dose of EDS was gradually increased from 2 to 10 mM, the proportion of cells showing normal apoptotic features gradually decreased. Intriguingly, treatment with 10 mM EDS did not result in death for most cells and was marked by an absence of DNA laddering and ultrastructural features of apoptosis and necrosis. However, incubation with 20 mM EDS resulted in necrosis.These results demonstrated that the effects of EDS on cell survival are not specific to Leydig cells, that different cell types have different sensitivities to EDS and that stimulation of the cAMP pathway may mitigate EDS action. The data obtained with H540 cells further revealed that EDS can induce two types of programmed cell death.
authors.affiliation: Department of Internal Medicine, Erasmus Medical Center Rotterdam, PO Box 1738, DR Rotterdam, The Netherlands.
authors.forename: F F G
authors.initials: FF
authors.lastname: Rommerts
authors.forename: L
authors.initials: L
authors.lastname: Kühne
authors.forename: G W A
authors.initials: GW
authors.lastname: van Cappellen
authors.forename: D M
authors.initials: DM
authors.lastname: Stocco
authors.forename: S R
authors.initials: SR
authors.lastname: King
authors.forename: A
authors.initials: A
authors.lastname: Jankowska
mesh_terms: D000477:Alkylating Agents / Q000494:pharmacology*; D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D002460:Cell Line; D045744:Cell Line, Tumor; D002462:Cell Membrane / Q000187:drug effects / Q000648:ultrastructure; D053938:DNA Fragmentation; D004305:Dose-Response Relationship, Drug; D007985:Leydig Cells / Q000166:cytology* / Q000648:ultrastructure; D008297:Male; D008698:Mesylates / Q000494:pharmacology*; D051379:Mice; D018613:Microscopy, Confocal; D008854:Microscopy, Electron; D008928:Mitochondria / Q000187:drug effects / Q000648:ultrastructure; D009336:Necrosis; D051381:Rats; D013997:Time Factors
chemical_list: D000477:Alkylating Agents; D008698:Mesylates; C002994:ethylene dimethanesulfonate